Pathology of the female reproductive tract 3 Flashcards
% of women with endometrial cancer presenting with menopausal bleeding
80%
Endometrium
Composed of glands in a specialised stroma with a specialised blood supply
Growth, maturation and regression of all three components is co-ordinated during each menstrual cycle
Endometrial cancer arises
In the glands of the endometrium
Name for a malignant neoplasm of glandular epithelium
Adenocarcinoma
Adenocarcinomas
From different parts of the body have different RF, pathogenesis, appearances, genetic abnormalities, prognosis and treatment
Subtypes of endometrial adenocarcinoma by morphology
Endometrioid
Serous
Clear cell
Mixed (previous 3)
Undifferentiated
Carcinosarcomas
Endometrioid
Show differentiation that resembles endometrial glands
Serous
Thought to resemble fallopian tube epithelium
Clear cell
Have clear cytoplasm
Type 1 endometrial adenocarcinoma
Age: 50-60s
Obesity: common
Oestrogenic stimulation: common
Precursor lesion: EIN, atypical hyperplasia
Transition: slow
Type: endometrioid
Spread: lymph nodes
Concurrent ovarian: common
Prognosis: good
Type 2 endometrial adenocarcinoma
Age: 60-70
Obesity: uncommon
Oestrogenic stimulation: uncommon
Precursor lesion: EIC
Transition: unknown
Type: serous, mixed
Spread: peritoneum
Concurrent ovarian: uncommon
Prognosis: poor
Molecular pathology
The cancer genome atlas (TCGA) classified endometrial cancer in 4 groups
Based on integrated genomic, transcriptomic and proteomic characteristics of c370 endometrial carcinoma
TCGA endometrial cancers
Ultramutated cancer 7%
Hypermutated cancer 28%
Endometrial cancer with low frequency of DNA copy number alterations 39%
Endometrial cancers with high frequency of DNA copy number alterations 26%
Precursor lesion in the cervix
Cervical intra-epithelial neoplasia (CIN)
Process is dysplasia
Precursor lesion in the endometrium
Atypical hyperplasia
Supported by temporal, genetic and morphological continuity with endometrioid endometrial adenocarcinoma